Recombinant multi-species c-Cbl/CBL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine c-Cbl/CBL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
The Alternative Names of target: 4732447J05Rik,C-CBL,CBL,CBL2,Casitas B-lineage lymphoma proto-oncogene,Cbl,Cbl-2,E3 ubiquitin-protein ligase CBL,FRA11B,NSLL,Proto-oncogene c-Cbl,RGD1561386,RING finger protein 55,RING-type E3 ubiquitin transferase CBL,RNF55,Signal transduction protein CBL,c-Cbl,c-cbl-like,cbl
Go
to c-Cbl/CBL products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T25309-Ag-1/ GM-Tg-hg-T25309-Ag-2 | Human c-Cbl/CBL protein | Human |
| GM-Tg-rg-T25309-Ag-1/ GM-Tg-rg-T25309-Ag-2 | Rat c-Cbl/CBL protein | Rat |
| GM-Tg-mg-T25309-Ag-1/ GM-Tg-mg-T25309-Ag-2 | Mouse c-Cbl/CBL protein | Mouse |
| GM-Tg-cynog-T25309-Ag-1/ GM-Tg-cynog-T25309-Ag-2 | Cynomolgus/Rhesus macaque c-Cbl/CBL protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T25309-Ag-1/ GM-Tg-felg-T25309-Ag-2 | Feline c-Cbl/CBL protein | Feline |
| GM-Tg-cang-T25309-Ag-1/ GM-Tg-cang-T25309-Ag-2 | Canine c-Cbl/CBL protein | Canine |
| GM-Tg-bovg-T25309-Ag-1/ GM-Tg-bovg-T25309-Ag-2 | Bovine c-Cbl/CBL protein | Bovine |
| GM-Tg-equg-T25309-Ag-1/ GM-Tg-equg-T25309-Ag-2 | Equine c-Cbl/CBL protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T25309-Ag-1/ GM-Tg-hg-T25309-Ag-2;
GM-Tg-rg-T25309-Ag-1/ GM-Tg-rg-T25309-Ag-2;
GM-Tg-mg-T25309-Ag-1/ GM-Tg-mg-T25309-Ag-2; GM-Tg-cynog-T25309-Ag-1/ GM-Tg-cynog-T25309-Ag-2; GM-Tg-felg-T25309-Ag-1/ GM-Tg-felg-T25309-Ag-2; GM-Tg-cang-T25309-Ag-1/ GM-Tg-cang-T25309-Ag-2; GM-Tg-bovg-T25309-Ag-1/ GM-Tg-bovg-T25309-Ag-2; GM-Tg-equg-T25309-Ag-1/ GM-Tg-equg-T25309-Ag-2 |
| Products Name | c-Cbl/CBL protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | c-Cbl/CBL |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine c-Cbl/CBL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.